Elan Win In IP Feud Over Skelaxin Confirmed By Judge
A Maryland federal judge on Thursday denied Classen Immunotherapies Inc.'s motion to reconsider or vacate a summary judgment granted to Irish pharmaceutical company Elan Pharmaceuticals Inc. in a stayed lawsuit over...To view the full article, register now.
Already a subscriber? Click here to view full article